The DOI matches its Crossref record.
Inhibition of murine natural killer cell activity by prostaglandins.
Abstract
The effect of prostaglandins (PG) on murine natural killer (NK) cell activity was examined. The addition of PGE1, PGE2, PGA1, or PGA2 to the cytotoxicity assay resulted in marked depression of NK activity, whereas addition of PGB1, PGB2, PGF1α, or PGF2α, resulted in little or no inhibition. The inhibition with PG was dependent on the concentration of PG added, occurred at all effector to target cell ratios, and was independent of the target cell used to measure NK activity. PG-mediated inhibition of NK activity was observed by using splenic effector cells from either euthymic or athymic mice and on both spontaneous and interferon-augmented NK activity. Maximal suppression of activity occurred when PG were present throughout the entire assay period, whereas pretreatment of effector cells with PG had minimal inhibitory effect. The susceptibility of NK activity to PG-mediated suppression could be modulated by overnight incubation of spleen cells at 37 °C, such that PG no longer inhibited NK reactivity. To examine the possible in vivo role of PG as regulators of NK activity, inhibitors of PG synthesis were administered to Moloney murine sarcoma-induced tumor-bearing mice with depressed NK activity. After treatment with indomethacin or aspirin, a marked restoration of NK activity to normal or near normal levels was demonstrated in tumor-bearing animals. These results indicate that PG are potent inhibitors of NK activity in vitro and suggest that under certain conditions PG may inhibit NK activity in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Exercise and the immune system: regulation, integration, and adaptation
Pedersen, B. K., & Hoffman-Goetz, L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1055 · Cited by 1,710
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Webb, D. R. (1980) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(80)90024-0 · Cited by 768
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin
Brown, M., & Jones, S. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.01180.x · Cited by 373
Heterogeneity of Natural Killer Cells
Ortaldo, J. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.359 · Cited by 358
Hyaluronan: Pharmaceutical Characterization and Drug Delivery
Liao, Y.-H., Jones, S. A., Forbes, B., Martin, G. P., & Brown, M. B. (2005) · Drug Delivery · doi:10.1080/10717540590952555 · Cited by 342
Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder
Knapp, D. W., Richardson, R. C., Chan, T. C. K., Bottoms, G. D., Widmer, W. R., DeNicola, D. B., Teclaw, R., Bonney, P. L., & Kuczek, T. (1994) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1994.tb03232.x · Cited by 303
Metadata
- Authors
- Brunda, M. J., Herberman, R. B., & Holden, H. T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1980-06-01
- Volume
- 124
- Issue
- 6
- Pages
- 2682-2687
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1550686374
- Cited by
- 417
- References
- 0
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.